Pharma & Healthcare
Global Central Nervous System Drugs Market Research Report 2025
- Sep 09, 25
- ID: 497328
- Pages: 92
- Figures: 88
- Views: 3
Report Scope
This report aims to provide a comprehensive presentation of the global market for Central Nervous System Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System Drugs.
The Central Nervous System Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Retail Pharmacy
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Central Nervous System Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Central Nervous System Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Central Nervous System Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System Drugs.
The Central Nervous System Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
EliLilly
Otsuka
Merck
AstraZeneca
Novartis
Takeda
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Retail Pharmacy
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Central Nervous System Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Central Nervous System Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Central Nervous System Drugs Market Overview
1.1 Product Definition
1.2 Central Nervous System Drugs by Type
1.2.1 Global Central Nervous System Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Central Nervous System Drugs by Application
1.3.1 Global Central Nervous System Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Central Nervous System Drugs Market Size Estimates and Forecasts
1.4.1 Global Central Nervous System Drugs Revenue 2020-2031
1.4.2 Global Central Nervous System Drugs Sales 2020-2031
1.4.3 Global Central Nervous System Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Central Nervous System Drugs Market Competition by Manufacturers
2.1 Global Central Nervous System Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Central Nervous System Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Central Nervous System Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Central Nervous System Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Central Nervous System Drugs, Product Type & Application
2.7 Global Key Manufacturers of Central Nervous System Drugs, Date of Enter into This Industry
2.8 Global Central Nervous System Drugs Market Competitive Situation and Trends
2.8.1 Global Central Nervous System Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Central Nervous System Drugs Players Market Share by Revenue
2.8.3 Global Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Central Nervous System Drugs Market Scenario by Region
3.1 Global Central Nervous System Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Central Nervous System Drugs Sales by Region: 2020-2031
3.2.1 Global Central Nervous System Drugs Sales by Region: 2020-2025
3.2.2 Global Central Nervous System Drugs Sales by Region: 2026-2031
3.3 Global Central Nervous System Drugs Revenue by Region: 2020-2031
3.3.1 Global Central Nervous System Drugs Revenue by Region: 2020-2025
3.3.2 Global Central Nervous System Drugs Revenue by Region: 2026-2031
3.4 North America Central Nervous System Drugs Market Facts & Figures by Country
3.4.1 North America Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Central Nervous System Drugs Sales by Country (2020-2031)
3.4.3 North America Central Nervous System Drugs Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Central Nervous System Drugs Market Facts & Figures by Country
3.5.1 Europe Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Central Nervous System Drugs Sales by Country (2020-2031)
3.5.3 Europe Central Nervous System Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Central Nervous System Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Central Nervous System Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Central Nervous System Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Central Nervous System Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Central Nervous System Drugs Market Facts & Figures by Country
3.7.1 Latin America Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Central Nervous System Drugs Sales by Country (2020-2031)
3.7.3 Latin America Central Nervous System Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Central Nervous System Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Central Nervous System Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Central Nervous System Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Central Nervous System Drugs Sales by Type (2020-2031)
4.1.1 Global Central Nervous System Drugs Sales by Type (2020-2025)
4.1.2 Global Central Nervous System Drugs Sales by Type (2026-2031)
4.1.3 Global Central Nervous System Drugs Sales Market Share by Type (2020-2031)
4.2 Global Central Nervous System Drugs Revenue by Type (2020-2031)
4.2.1 Global Central Nervous System Drugs Revenue by Type (2020-2025)
4.2.2 Global Central Nervous System Drugs Revenue by Type (2026-2031)
4.2.3 Global Central Nervous System Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Central Nervous System Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Central Nervous System Drugs Sales by Application (2020-2031)
5.1.1 Global Central Nervous System Drugs Sales by Application (2020-2025)
5.1.2 Global Central Nervous System Drugs Sales by Application (2026-2031)
5.1.3 Global Central Nervous System Drugs Sales Market Share by Application (2020-2031)
5.2 Global Central Nervous System Drugs Revenue by Application (2020-2031)
5.2.1 Global Central Nervous System Drugs Revenue by Application (2020-2025)
5.2.2 Global Central Nervous System Drugs Revenue by Application (2026-2031)
5.2.3 Global Central Nervous System Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Central Nervous System Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biogen
6.1.1 Biogen Company Information
6.1.2 Biogen Description and Business Overview
6.1.3 Biogen Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biogen Central Nervous System Drugs Product Portfolio
6.1.5 Biogen Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Central Nervous System Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Central Nervous System Drugs Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Central Nervous System Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Central Nervous System Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 EliLilly
6.6.1 EliLilly Company Information
6.6.2 EliLilly Description and Business Overview
6.6.3 EliLilly Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 EliLilly Central Nervous System Drugs Product Portfolio
6.6.5 EliLilly Recent Developments/Updates
6.7 Otsuka
6.7.1 Otsuka Company Information
6.7.2 Otsuka Description and Business Overview
6.7.3 Otsuka Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Otsuka Central Nervous System Drugs Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck Central Nervous System Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Central Nervous System Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Central Nervous System Drugs Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Company Information
6.11.2 Takeda Description and Business Overview
6.11.3 Takeda Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takeda Central Nervous System Drugs Product Portfolio
6.11.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Central Nervous System Drugs Industry Chain Analysis
7.2 Central Nervous System Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Central Nervous System Drugs Production Mode & Process Analysis
7.4 Central Nervous System Drugs Sales and Marketing
7.4.1 Central Nervous System Drugs Sales Channels
7.4.2 Central Nervous System Drugs Distributors
7.5 Central Nervous System Drugs Customer Analysis
8 Central Nervous System Drugs Market Dynamics
8.1 Central Nervous System Drugs Industry Trends
8.2 Central Nervous System Drugs Market Drivers
8.3 Central Nervous System Drugs Market Challenges
8.4 Central Nervous System Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Central Nervous System Drugs by Type
1.2.1 Global Central Nervous System Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Central Nervous System Drugs by Application
1.3.1 Global Central Nervous System Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Central Nervous System Drugs Market Size Estimates and Forecasts
1.4.1 Global Central Nervous System Drugs Revenue 2020-2031
1.4.2 Global Central Nervous System Drugs Sales 2020-2031
1.4.3 Global Central Nervous System Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Central Nervous System Drugs Market Competition by Manufacturers
2.1 Global Central Nervous System Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Central Nervous System Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Central Nervous System Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Central Nervous System Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Central Nervous System Drugs, Product Type & Application
2.7 Global Key Manufacturers of Central Nervous System Drugs, Date of Enter into This Industry
2.8 Global Central Nervous System Drugs Market Competitive Situation and Trends
2.8.1 Global Central Nervous System Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Central Nervous System Drugs Players Market Share by Revenue
2.8.3 Global Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Central Nervous System Drugs Market Scenario by Region
3.1 Global Central Nervous System Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Central Nervous System Drugs Sales by Region: 2020-2031
3.2.1 Global Central Nervous System Drugs Sales by Region: 2020-2025
3.2.2 Global Central Nervous System Drugs Sales by Region: 2026-2031
3.3 Global Central Nervous System Drugs Revenue by Region: 2020-2031
3.3.1 Global Central Nervous System Drugs Revenue by Region: 2020-2025
3.3.2 Global Central Nervous System Drugs Revenue by Region: 2026-2031
3.4 North America Central Nervous System Drugs Market Facts & Figures by Country
3.4.1 North America Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Central Nervous System Drugs Sales by Country (2020-2031)
3.4.3 North America Central Nervous System Drugs Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Central Nervous System Drugs Market Facts & Figures by Country
3.5.1 Europe Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Central Nervous System Drugs Sales by Country (2020-2031)
3.5.3 Europe Central Nervous System Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Central Nervous System Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Central Nervous System Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Central Nervous System Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Central Nervous System Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Central Nervous System Drugs Market Facts & Figures by Country
3.7.1 Latin America Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Central Nervous System Drugs Sales by Country (2020-2031)
3.7.3 Latin America Central Nervous System Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Central Nervous System Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Central Nervous System Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Central Nervous System Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Central Nervous System Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Central Nervous System Drugs Sales by Type (2020-2031)
4.1.1 Global Central Nervous System Drugs Sales by Type (2020-2025)
4.1.2 Global Central Nervous System Drugs Sales by Type (2026-2031)
4.1.3 Global Central Nervous System Drugs Sales Market Share by Type (2020-2031)
4.2 Global Central Nervous System Drugs Revenue by Type (2020-2031)
4.2.1 Global Central Nervous System Drugs Revenue by Type (2020-2025)
4.2.2 Global Central Nervous System Drugs Revenue by Type (2026-2031)
4.2.3 Global Central Nervous System Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Central Nervous System Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Central Nervous System Drugs Sales by Application (2020-2031)
5.1.1 Global Central Nervous System Drugs Sales by Application (2020-2025)
5.1.2 Global Central Nervous System Drugs Sales by Application (2026-2031)
5.1.3 Global Central Nervous System Drugs Sales Market Share by Application (2020-2031)
5.2 Global Central Nervous System Drugs Revenue by Application (2020-2031)
5.2.1 Global Central Nervous System Drugs Revenue by Application (2020-2025)
5.2.2 Global Central Nervous System Drugs Revenue by Application (2026-2031)
5.2.3 Global Central Nervous System Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Central Nervous System Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Biogen
6.1.1 Biogen Company Information
6.1.2 Biogen Description and Business Overview
6.1.3 Biogen Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Biogen Central Nervous System Drugs Product Portfolio
6.1.5 Biogen Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Central Nervous System Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva
6.3.1 Teva Company Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Central Nervous System Drugs Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Central Nervous System Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Johnson & Johnson Central Nervous System Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 EliLilly
6.6.1 EliLilly Company Information
6.6.2 EliLilly Description and Business Overview
6.6.3 EliLilly Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 EliLilly Central Nervous System Drugs Product Portfolio
6.6.5 EliLilly Recent Developments/Updates
6.7 Otsuka
6.7.1 Otsuka Company Information
6.7.2 Otsuka Description and Business Overview
6.7.3 Otsuka Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Otsuka Central Nervous System Drugs Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
6.8 Merck
6.8.1 Merck Company Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck Central Nervous System Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca Central Nervous System Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Central Nervous System Drugs Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Takeda
6.11.1 Takeda Company Information
6.11.2 Takeda Description and Business Overview
6.11.3 Takeda Central Nervous System Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takeda Central Nervous System Drugs Product Portfolio
6.11.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Central Nervous System Drugs Industry Chain Analysis
7.2 Central Nervous System Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Central Nervous System Drugs Production Mode & Process Analysis
7.4 Central Nervous System Drugs Sales and Marketing
7.4.1 Central Nervous System Drugs Sales Channels
7.4.2 Central Nervous System Drugs Distributors
7.5 Central Nervous System Drugs Customer Analysis
8 Central Nervous System Drugs Market Dynamics
8.1 Central Nervous System Drugs Industry Trends
8.2 Central Nervous System Drugs Market Drivers
8.3 Central Nervous System Drugs Market Challenges
8.4 Central Nervous System Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Central Nervous System Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Central Nervous System Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Central Nervous System Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Central Nervous System Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Central Nervous System Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Central Nervous System Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Central Nervous System Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Central Nervous System Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Central Nervous System Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Central Nervous System Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Central Nervous System Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Central Nervous System Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Central Nervous System Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Central Nervous System Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Central Nervous System Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Central Nervous System Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Central Nervous System Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Central Nervous System Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Central Nervous System Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Central Nervous System Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Central Nervous System Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Central Nervous System Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Central Nervous System Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Central Nervous System Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Central Nervous System Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Central Nervous System Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Central Nervous System Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Central Nervous System Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Central Nervous System Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Central Nervous System Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Central Nervous System Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Central Nervous System Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Central Nervous System Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Central Nervous System Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Central Nervous System Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Central Nervous System Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Central Nervous System Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Central Nervous System Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Central Nervous System Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Central Nervous System Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Central Nervous System Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Central Nervous System Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Central Nervous System Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Central Nervous System Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. Biogen Company Information
Table 71. Biogen Description and Business Overview
Table 72. Biogen Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Biogen Central Nervous System Drugs Product
Table 74. Biogen Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Central Nervous System Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Teva Central Nervous System Drugs Product
Table 84. Teva Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Central Nervous System Drugs Product
Table 89. Novartis Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Central Nervous System Drugs Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. EliLilly Company Information
Table 96. EliLilly Description and Business Overview
Table 97. EliLilly Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. EliLilly Central Nervous System Drugs Product
Table 99. EliLilly Recent Developments/Updates
Table 100. Otsuka Company Information
Table 101. Otsuka Description and Business Overview
Table 102. Otsuka Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Otsuka Central Nervous System Drugs Product
Table 104. Otsuka Recent Developments/Updates
Table 105. Merck Company Information
Table 106. Merck Description and Business Overview
Table 107. Merck Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Merck Central Nervous System Drugs Product
Table 109. Merck Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. AstraZeneca Central Nervous System Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Novartis Central Nervous System Drugs Product
Table 119. Novartis Recent Developments/Updates
Table 120. Takeda Company Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Takeda Central Nervous System Drugs Product
Table 124. Takeda Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Central Nervous System Drugs Distributors List
Table 128. Central Nervous System Drugs Customers List
Table 129. Central Nervous System Drugs Market Trends
Table 130. Central Nervous System Drugs Market Drivers
Table 131. Central Nervous System Drugs Market Challenges
Table 132. Central Nervous System Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Central Nervous System Drugs
Figure 2. Global Central Nervous System Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System Drugs Market Share by Type: 2024 & 2031
Figure 4. OTC Product Picture
Figure 5. Rx Drugs Product Picture
Figure 6. Global Central Nervous System Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Central Nervous System Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Global Central Nervous System Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Central Nervous System Drugs Market Size (2020-2031) & (US$ Million)
Figure 12. Global Central Nervous System Drugs Sales (2020-2031) & (K Units)
Figure 13. Global Central Nervous System Drugs Average Price (USD/Unit) & (2020-2031)
Figure 14. Central Nervous System Drugs Report Years Considered
Figure 15. Central Nervous System Drugs Sales Share by Manufacturers in 2024
Figure 16. Global Central Nervous System Drugs Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Central Nervous System Drugs Players: Market Share by Revenue in Central Nervous System Drugs in 2024
Figure 18. Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Central Nervous System Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 21. North America Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 22. the United States Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 25. Europe Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 26. Germany Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Central Nervous System Drugs Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Central Nervous System Drugs Revenue Market Share by Region (2020-2031)
Figure 33. China Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 43. Latin America Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Central Nervous System Drugs by Type (2020-2031)
Figure 53. Global Revenue Market Share of Central Nervous System Drugs by Type (2020-2031)
Figure 54. Global Central Nervous System Drugs Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Central Nervous System Drugs by Application (2020-2031)
Figure 56. Global Revenue Market Share of Central Nervous System Drugs by Application (2020-2031)
Figure 57. Global Central Nervous System Drugs Price (USD/Unit) by Application (2020-2031)
Figure 58. Central Nervous System Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Central Nervous System Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Central Nervous System Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Central Nervous System Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Central Nervous System Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Central Nervous System Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Central Nervous System Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Central Nervous System Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Central Nervous System Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Central Nervous System Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Central Nervous System Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Central Nervous System Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Central Nervous System Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Central Nervous System Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Central Nervous System Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Central Nervous System Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Central Nervous System Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Central Nervous System Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Central Nervous System Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Central Nervous System Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Central Nervous System Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Central Nervous System Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Central Nervous System Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Central Nervous System Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Central Nervous System Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Central Nervous System Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Central Nervous System Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Central Nervous System Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Central Nervous System Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Central Nervous System Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Central Nervous System Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Central Nervous System Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Central Nervous System Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Central Nervous System Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Central Nervous System Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Central Nervous System Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Central Nervous System Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Central Nervous System Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Central Nervous System Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Central Nervous System Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Central Nervous System Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Central Nervous System Drugs Price (USD/Unit) by Type (2020-2025)
Table 59. Global Central Nervous System Drugs Price (USD/Unit) by Type (2026-2031)
Table 60. Global Central Nervous System Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Central Nervous System Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Central Nervous System Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Central Nervous System Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Central Nervous System Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Central Nervous System Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Central Nervous System Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Central Nervous System Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Central Nervous System Drugs Price (USD/Unit) by Application (2020-2025)
Table 69. Global Central Nervous System Drugs Price (USD/Unit) by Application (2026-2031)
Table 70. Biogen Company Information
Table 71. Biogen Description and Business Overview
Table 72. Biogen Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Biogen Central Nervous System Drugs Product
Table 74. Biogen Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Central Nervous System Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Teva Company Information
Table 81. Teva Description and Business Overview
Table 82. Teva Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Teva Central Nervous System Drugs Product
Table 84. Teva Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Central Nervous System Drugs Product
Table 89. Novartis Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Johnson & Johnson Central Nervous System Drugs Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. EliLilly Company Information
Table 96. EliLilly Description and Business Overview
Table 97. EliLilly Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. EliLilly Central Nervous System Drugs Product
Table 99. EliLilly Recent Developments/Updates
Table 100. Otsuka Company Information
Table 101. Otsuka Description and Business Overview
Table 102. Otsuka Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Otsuka Central Nervous System Drugs Product
Table 104. Otsuka Recent Developments/Updates
Table 105. Merck Company Information
Table 106. Merck Description and Business Overview
Table 107. Merck Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Merck Central Nervous System Drugs Product
Table 109. Merck Recent Developments/Updates
Table 110. AstraZeneca Company Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. AstraZeneca Central Nervous System Drugs Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Novartis Central Nervous System Drugs Product
Table 119. Novartis Recent Developments/Updates
Table 120. Takeda Company Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Central Nervous System Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Takeda Central Nervous System Drugs Product
Table 124. Takeda Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Central Nervous System Drugs Distributors List
Table 128. Central Nervous System Drugs Customers List
Table 129. Central Nervous System Drugs Market Trends
Table 130. Central Nervous System Drugs Market Drivers
Table 131. Central Nervous System Drugs Market Challenges
Table 132. Central Nervous System Drugs Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Central Nervous System Drugs
Figure 2. Global Central Nervous System Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Central Nervous System Drugs Market Share by Type: 2024 & 2031
Figure 4. OTC Product Picture
Figure 5. Rx Drugs Product Picture
Figure 6. Global Central Nervous System Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Central Nervous System Drugs Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Retail Pharmacy
Figure 10. Global Central Nervous System Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Central Nervous System Drugs Market Size (2020-2031) & (US$ Million)
Figure 12. Global Central Nervous System Drugs Sales (2020-2031) & (K Units)
Figure 13. Global Central Nervous System Drugs Average Price (USD/Unit) & (2020-2031)
Figure 14. Central Nervous System Drugs Report Years Considered
Figure 15. Central Nervous System Drugs Sales Share by Manufacturers in 2024
Figure 16. Global Central Nervous System Drugs Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Central Nervous System Drugs Players: Market Share by Revenue in Central Nervous System Drugs in 2024
Figure 18. Central Nervous System Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Central Nervous System Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 21. North America Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 22. the United States Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 25. Europe Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 26. Germany Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. UK Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Central Nervous System Drugs Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Central Nervous System Drugs Revenue Market Share by Region (2020-2031)
Figure 33. China Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 43. Latin America Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Central Nervous System Drugs Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Central Nervous System Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Central Nervous System Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Central Nervous System Drugs by Type (2020-2031)
Figure 53. Global Revenue Market Share of Central Nervous System Drugs by Type (2020-2031)
Figure 54. Global Central Nervous System Drugs Price (USD/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Central Nervous System Drugs by Application (2020-2031)
Figure 56. Global Revenue Market Share of Central Nervous System Drugs by Application (2020-2031)
Figure 57. Global Central Nervous System Drugs Price (USD/Unit) by Application (2020-2031)
Figure 58. Central Nervous System Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232